Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (77) Tegretol (carbamazepine), Ciba Pharmaceuticals,
...Newly Approved Drug Therapies (77) Tegretol (carbamazepine), Ciba Pharmaceuticals, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Tegretol (carbamazepine) Company: Ciba Pharmaceuticals Approval Status: Approved March 1996 Treatment Area: epilepsy General Information Tegretol, an ...
View Page

2.  Newly Approved Drug Therapies (97) Tegretol XR (carbamazepine), Ciba-Geigy,
...Newly Approved Drug Therapies (97) Tegretol XR (carbamazepine), Ciba-Geigy, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Tegretol XR (carbamazepine) Company: Ciba-Geigy Approval Status: Approved May 1996 Treatment Area: epileptic seizures General Information Tegretol ...
View Page

3.  Study Posting (3825) Trial #72109, Bipolar Disorders, Irving, TX
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

4.  Study Posting (3825) Trial #72108, Bipolar Disorders, Houston, TX
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

5.  Study Posting (3825) Trial #72102, Bipolar Disorders, Raleigh, NC
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

6.  Study Posting (3825) Trial #72110, Bipolar Disorders, Atlanta, GA
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

7.  Study Posting (3825) Trial #72111, Bipolar Disorders, Cerritos, CA
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

8.  Study Posting (3825) Trial #72107, Bipolar Disorders, Scottsdale, AZ
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

9.  Study Posting (3825) Trial #72106, Bipolar Disorders, Austin, TX
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

10.  Study Posting (3825) Trial #72104, Bipolar Disorders, Oklahoma City, OK
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

11.  Study Posting (3825) Trial #72112, Bipolar Disorders, San Diego, CA
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

12.  Study Posting (3825) Trial #72103, Bipolar Disorders, National City, CA
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

13.  Study Posting (3825) Trial #72113, Bipolar Disorders, Garden Grove, CA
...Trial Information A 12-week clinical research study to evaluate the efficacy and safety of carbamazepine extended release capsules administered once daily vs. twice daily in the treatment of manic symptoms of Bipolar I Disorder. Study participants will receive carbamazepine extended release capsules either once daily or twice daily. Patients will be allowed to continue ...
View Page

14.  Study Posting (3826) Trial #72121, Bipolar Disorders, Irving, TX
...Irving, TX Trial Information An 8-week clinical research study to evaluate the use of carbamazepine extended release capsules in combination with other psychotropic medications for the treatment of Bipolar I ...
...quetiapine or aripiprazole alone or in combination with a mood stabilizer (lithium, valproate or lamotrigine). Carbamazepine extended release capsules will be added to current therapy as lamotrigine and valproate are slowly ...
View Page

15.  Study Posting (3826) Trial #72120, Bipolar Disorders, Houston, TX
...Houston, TX Trial Information An 8-week clinical research study to evaluate the use of carbamazepine extended release capsules in combination with other psychotropic medications for the treatment of Bipolar I ...
...quetiapine or aripiprazole alone or in combination with a mood stabilizer (lithium, valproate or lamotrigine). Carbamazepine extended release capsules will be added to current therapy as lamotrigine and valproate are slowly ...
View Page

16.  Study Posting (3826) Trial #72114, Bipolar Disorders, Raleigh, NC
...Raleigh, NC Trial Information An 8-week clinical research study to evaluate the use of carbamazepine extended release capsules in combination with other psychotropic medications for the treatment of Bipolar I ...
...quetiapine or aripiprazole alone or in combination with a mood stabilizer (lithium, valproate or lamotrigine). Carbamazepine extended release capsules will be added to current therapy as lamotrigine and valproate are slowly ...
View Page

17.  Study Posting (3826) Trial #72122, Bipolar Disorders, Atlanta, GA
...Atlanta, GA Trial Information An 8-week clinical research study to evaluate the use of carbamazepine extended release capsules in combination with other psychotropic medications for the treatment of Bipolar I ...
...quetiapine or aripiprazole alone or in combination with a mood stabilizer (lithium, valproate or lamotrigine). Carbamazepine extended release capsules will be added to current therapy as lamotrigine and valproate are slowly ...
View Page

18.  Study Posting (3826) Trial #72123, Bipolar Disorders, Cerritos, CA
...Cerritos, CA Trial Information An 8-week clinical research study to evaluate the use of carbamazepine extended release capsules in combination with other psychotropic medications for the treatment of Bipolar I ...
...quetiapine or aripiprazole alone or in combination with a mood stabilizer (lithium, valproate or lamotrigine). Carbamazepine extended release capsules will be added to current therapy as lamotrigine and valproate are slowly ...
View Page

19.  Study Posting (3826) Trial #72119, Bipolar Disorders, Scottsdale, AZ
...Scottsdale, AZ Trial Information An 8-week clinical research study to evaluate the use of carbamazepine extended release capsules in combination with other psychotropic medications for the treatment of Bipolar I ...
...quetiapine or aripiprazole alone or in combination with a mood stabilizer (lithium, valproate or lamotrigine). Carbamazepine extended release capsules will be added to current therapy as lamotrigine and valproate are slowly ...
View Page

20.  Study Posting (3826) Trial #72118, Bipolar Disorders, Austin, TX
...Austin, TX Trial Information An 8-week clinical research study to evaluate the use of carbamazepine extended release capsules in combination with other psychotropic medications for the treatment of Bipolar I ...
...quetiapine or aripiprazole alone or in combination with a mood stabilizer (lithium, valproate or lamotrigine). Carbamazepine extended release capsules will be added to current therapy as lamotrigine and valproate are slowly ...
View Page